XML 15 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 31,836 $ 144,583
Short-term investments 300,535 27,796
Accounts receivable, net 64,652 41,874
Inventory 39,032 10,108
Prepaid expenses and other current assets 11,193 3,702
Total current assets 447,248 228,063
Property and equipment, net 14,677 5,981
Other assets 254 263
Total assets 462,179 234,307
Current liabilities:    
Accounts payable 16,863 18,769
Accrued clinical and manufacturing liabilities 24,470 26,920
Accrued payroll and employee liabilities 13,397 8,860
Other accrued liabilities 32,715 17,175
Deferred revenue 2,763
Promissory note payable to related party 25,000
Convertible notes payable to related parties, net of discount 4,574 3,684
Total current liabilities 92,019 103,171
Commitments and contingencies (see Note 6)
Stockholders’ equity (deficit):    
Preferred stock, $0.01 par value: 2,500 shares authorized; no shares issued or outstanding at December 31, 2018 and 2017
Common stock, $0.01 par value: 150,000 shares authorized; 78,174 and 64,609 shares issued and outstanding at December 31, 2018 and 2017, respectively 782 646
Additional paid-in capital 1,330,186 913,955
Accumulated other comprehensive loss (87) (10)
Accumulated deficit (960,721) (783,455)
Total stockholders’ equity 370,160 131,136
Total liabilities and stockholders’ equity $ 462,179 $ 234,307